Drug Type Bispecific antibody |
Synonyms CX 10759, CX-10759 |
Target |
Mechanism IgE receptors(IgE receptor antagonists), Immunosuppressants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypersensitivity | Preclinical | - | - |